DEFENDANT NAME: SkinMedica and Allergan Inc.
CASE NUMBER: 8:14-cv-00420
COURT: U.S. District Court for the Central District of California
PRACTICE AREA: Pharmaceutical Fraud
STATUS: Active
DATE FILED: 03/19/14



Consumers have filed a proposed class-action lawsuit against Allergan Inc. (NYSE: AGN) and its pharmaceutical company subsidiary, SkinMedica, claiming that the companies have misbranded and unlawfully marketed Tissue Nutrient Solution (TNS), a skin-care product line containing human growth factors obtained from human foreskin tissue which could increase the risk of cancer and pose other health risks, according to the complaint.

The lawsuit, filed by consumer-rights law firm Hagens Berman in the U.S. District Court for the Central District of California, claims that for at least the past four years, SkinMedica has failed to disclose significant safety concerns associated with TNS products while marketing the products without appropriate government approval, proper labeling, or adequate safety studies.

According to the firm’s investigation, SkinMedica’s TNS products, which have been sold nationally through doctors’ offices and retailers, contain a proprietary mix of “human growth factors” derived from human foreskin tissue. Human growth factors are intended to mobilize, stimulate, or otherwise alter the production of cells, including the ability to initiate cell division, which could stimulate growth of cancerous tumor cells, according to the complaint.

The suit alleges that in marketing their TNS products, Allergan and its subsidiary SkinMedica did not adequately disclose the health risks associated with these growth factors.

SkinMedica’s TNS products – which the company calls “cosmeceuticals” – did not have government approval and could not be sold lawfully in the U.S. without such approval, something else the company did not disclose to consumers, according to the complaint. The suit alleges that because neither the U.S. Food and Drug Administration nor the California Department of Public Health found TNS products to be safe for their intended use, and because TNS products omit required disclosures relating to safety concerns, the products have been misbranded under both federal laws and parallel state laws.

The lawsuit is a proposed class action based upon California’s consumer protection laws, and seeks to represent a class of all persons in the U.S. who purchased SkinMedica’s TNS products during the last four years.

Concerned consumers are encouraged to contact Hagens Berman by emailing or calling 206-623-7292.


Josette Ruhnke v. SkinMedica Inc. et al.

Hagens Berman purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Back to all cases


Please fill out the form below and we will get back to you as soon as we can.
Preferred Contact Method *
Select a State *
How Did You Hear About This Case/Investigation? *
How Has This Issue Affected You? *

Case videos

Case Gallery

Case Timeline

05/12/15: Motion for Class Certification

Plaintiffs ask court to certify a nationwide class covering everyone who purchased TNS since March 2010.

09/05/14: Motion to Dismiss Denied

U.S. District Judge David O. Carter denies defendants’ motion to dismiss. more »

03/19/14: Complaint Filed

Hagens Berman files complaint.